User profiles for Anne-Marie Gerdes

Anne-Marie Gerdes

Professor of Clinical Genetics, University of Copenhagen
Verified email at regionh.dk
Cited by 18646

Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

…, L Foretova, YY Tan, CF Singer, E Olah, AM Gerdes… - Jama, 2017 - jamanetwork.com
Importance The clinical management ofBRCA1andBRCA2mutation carriers requires accurate,
prospective cancer risk estimates. Objectives To estimate age-specific risks of breast, …

[HTML][HTML] Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

J Burn, AM Gerdes, F Macrae, JP Mecklin, G Moeslein… - The Lancet, 2011 - thelancet.com
Background Observational studies report reduced colorectal cancer in regular aspirin
consumers. Randomised controlled trials have shown reduced risk of adenomas but none have …

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 …

…, L Senter, K Sweet, M Thomassen, AM Gerdes… - … Biomarkers & Prevention, 2012 - AACR
Background: Previously, small studies have found that BRCA1 and BRCA2 breast tumors
differ in their pathology. Analysis of larger datasets of mutation carriers should allow further …

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

…, SL Neuhausen, YC Ding, B Ejlertsen, AM Gerdes… - Jama, 2015 - jamanetwork.com
Importance Limited information about the relationship between specific mutations
inBRCA1orBRCA2(BRCA1/2) and cancer risk exists. Objective To identify mutation-specific cancer …

Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD'(C4CMMRD)

…, O Caron, C Colas, N Entz-Werle, AM Gerdes… - Journal of medical …, 2014 - jmg.bmj.com
Constitutional mismatch repair deficiency (CMMRD) syndrome is a distinct childhood cancer
predisposition syndrome that results from biallelic germline mutations in one of the four …

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general …

…, K Harbst, J Rantala, H Ehrencrona, AM Gerdes… - Nature …, 2010 - nature.com
Germline BRCA1 mutations predispose to breast cancer. To identify genetic modifiers of this
risk, we performed a genome-wide association study in 1,193 individuals with BRCA1 …

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

…, A Gentry-Maharaj, AM Gerdes… - Nature …, 2017 - nature.com
To identify common alleles associated with different histotypes of epithelial ovarian cancer (EOC),
we pooled data from multiple genome-wide genotyping projects totaling 25,509 EOC …

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

…, YC Ding, TVO Hansen, L Jønson, AM Gerdes… - Nature …, 2015 - nature.com
Genome-wide association studies (GWAS) have identified 12 epithelial ovarian cancer (EOC)
susceptibility alleles. The pattern of association at these loci is consistent in BRCA1 and …

[PDF][PDF] Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

…, IL Andrulis, H Ozcelik, AM Gerdes… - The American Journal of …, 2008 - cell.com
Germline mutations in BRCA1 and BRCA2 confer high risks of breast cancer. However,
evidence suggests that these risks are modified by other genetic or environmental factors that …

[HTML][HTML] Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a …

…, FE McRonald, L Bertario, DG Evans, AM Gerdes… - The Lancet, 2020 - thelancet.com
Background Lynch syndrome is associated with an increased risk of colorectal cancer and
with a broader spectrum of cancers, especially endometrial cancer. In 2011, our group …